This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Other. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,570 Years Active: 2009
Title: Salvatore Siena: Innovator in Cancer Treatment
Introduction
Salvatore Siena is a prominent inventor based in Milan, Italy. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on the epidermal growth factor receptor (EGFr) and its implications in cancer therapy.
Latest Patents
Salvatore Siena holds a patent related to the epidermal growth factor receptor gene copy number. This patent outlines methods for predicting the efficacy of anti-EGFr-specific binding agent treatments in cancer patients. The invention provides valuable insights into how these treatments can be optimized for better patient outcomes.
Career Highlights
Throughout his career, Salvatore Siena has worked with notable companies, including Amgen Inc. His expertise in the field has allowed him to contribute to advancements in cancer research and treatment methodologies. His innovative approaches have garnered attention and respect within the scientific community.
Collaborations
Salvatore has collaborated with esteemed colleagues such as Mauro Moroni and Alberto Bardelli. These partnerships have facilitated the exchange of ideas and fostered advancements in cancer treatment strategies.
Conclusion
Salvatore Siena's contributions to cancer treatment through his patented methods and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for improved therapeutic approaches in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile